US FDA Commissioner Scott Gottlieb announced that the agency will be instituting regulatory clarity on the real-world evidence front, but also called on industry to take its chances in using such an approach in drug development.
"This takes a little bit of risk-taking on the part of sponsors who have to do something different in the...




